Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Intervention 1: Intervention group: Daily consumption of 250 grams of Ash Kardeh prepared by traditional fermentation method along whit receiving the usual treatment of diabetes for 6 weeks. Intervent
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: Diabetic patients with type 2 diabetes who have been diagnosed for six months and have a FBS equal to or greater than 126 mg / dL, according to the American Diabetes Association (ADA) Diagnostic Protocol or an endocrinologist has confirmed their diabetes. No use of Ash Kardeh and other traditional fermented products for 3 months prior to intervention. The patient should be between the ages of 30 and 65 years.
Exclusion criteria
Exclusion criteria: Having other chronic diseases, such as heart disease, kidney disease, liver disease, lung disease, parathyroid disease, pancreatitis, endocarditis, cancer, asthma and allergies. Gastrointestinal problems and short bowel syndrome. Treatment with immunosuppressive drugs. Consumption of alcoholic beverages. Smoking. Being an athlete and doing heavy sports activities. Pregnancy and lactation. Following diets over the past 6 months. Body mass index greater than 35 kg / m2.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Average fasting blood glucose equal to or greater than 126 mg/dL. Timepoint: At baseline (before intervention) and at the end of the study (42 days after starting consumption Ash). Method of measurement: Fasting blood glucose measurement by enzymatic and calorimetric method (glucose oxidase assay) using Pars Azmoon kits (mg/dL).;Mean systolic blood pressure equal to or greater than 120 mm Hg. Timepoint: At baseline (before intervention) and at the end of the study (42 days after starting consumption Ash). Method of measurement: Mercury barometer.;Mean diastolic blood pressure equal to or greater than 80 mm Hg. Timepoint: At baseline (before intervention) and at the end of the study (42 days after starting consumption Ash). Method of measurement: Mercury barometer.;Average total cholesterol equal to or greater than 199 mg/dL. Timepoint: At baseline (before intervention) and at the end of the study (42 days after starting consumption Ash). Method of measurement: Measurement of total cholesterol level using Pars Azmoon kits and auto analyzer.;Average HDL cholesterol equal to or less than 40 mg/dL. Timepoint: At baseline (before intervention) and at the end of the study (42 days after starting consumption Ash). Method of measurement: Measurement of total cholesterol level using Pars Azmoon kits and auto analyzer.;Average triglycerides equal to or greater than 199 mg/dL. Timepoint: At baseline (before intervention) and at the end of the study (42 days after starting consumption Ash). Method of measurement: Measurement of total cholesterol level using Pars Azmoon kits and auto analyzer.;Average LDL cholesterol equal to or greater than 130 mg/dL. Timepoint: At baseline (before intervention) and at the end of the study (42 days after starting consumption Ash). Method of measurement: Measurement of LDL cholesterol by Friedwald formula [LDL = Chol - (TG / 5 + HDL)], with plasma triglyceride concentrations below 400 mg/dL. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossien Imani
Tehran University of Medical Sciences
Outcome results
None listed